Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MMP8 | P22894 | 5/20 | 0.44 |
| ▸ | MMP13 | P45452 | 5/20 | 0.44 |
| ▸ | BMP1 | P13497 | 8/20 | 0.43 |
| ▸ | MMP9 | P14780 | 8/20 | 0.40 |
| ▸ | MMP2 | P08253 | 7/20 | 0.40 |
| ▸ | MMP1 | P03956 | 2/20 | 0.40 |
| ▸ | MMP3 | P08254 | 2/20 | 0.40 |
| ▸ | MMP7 | P09237 | 2/20 | 0.40 |
| ▸ | MEN1 | O00255 | 1/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7423905 | 1.00 | MMP8 (0.44) | MMP8MMP13BMP1MMP9MMP2 | |
| SCHEMBL6056888 | 0.90 | BMP1 (0.49) | MMP8MMP13BMP1MMP9MMP2 | |
| SCHEMBL6056891 | 0.90 | BMP1 (0.49) | MMP8MMP13BMP1MMP9MMP2 | |
| SCHEMBL6852350 | 0.90 | BMP1 (0.49) | MMP8MMP13BMP1MMP9MMP2 | |
| Hydrochloric Acid SCHEMBL7478395 | 0.90 | BMP1 (0.48) | MMP8MMP13BMP1MMP9MMP2 | |
| Hydrochloric Acid SCHEMBL7478391 | 0.90 | BMP1 (0.48) | MMP8MMP13BMP1MMP9MMP2 | |
| SCHEMBL7343511 | 0.88 | MMP9 (0.45) | MMP8MMP13BMP1MMP9MMP2 | |
| SCHEMBL7343507 | 0.88 | MMP9 (0.45) | MMP8MMP13BMP1MMP9MMP2 | |
| Trifluoroacetic Acid SCHEMBL7548425 | 0.87 | BMP1 (0.46) | MMP8MMP13BMP1MMP9MMP2 | |
| Trifluoroacetic Acid SCHEMBL7548420 | 0.87 | BMP1 (0.46) | MMP8MMP13BMP1MMP9MMP2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0873312-B1 | ALPHA-SUBSTITUTED ARYLSULPHONAMIDO HYDROXAMIC ACIDS AS TNF-ALPHA AND MATRIX METALLOPROTEINASE INHIBITORS | NOVARTIS AG (CH) | 2002-06-12 | — | — | EP | disclosed |
| EP-0873312-A1 | ALPHA-SUBSTITUTED ARYLSULPHONAMIDO HYDROXAMIC ACIDS AS TNF-ALPHA AND MATRIX METALLOPROTEINASE INHIBITORS | Novartis AG (CH) | 1998-10-28 | — | — | EP | disclosed |
| WO-1997022587-A1 | ALPHA-SUBSTITUTED ARYLSULPHONAMIDO HYDROXAMIC ACIDS AS TNF-ALPHA AND MATRIX METALLOPROTEINASE INHIBITORS | NOVARTIS AG (CH) | 1997-06-26 | — | — | WO | disclosed |